<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01255670</url>
  </required_header>
  <id_info>
    <org_study_id>224/13/03/02/2009</org_study_id>
    <nct_id>NCT01255670</nct_id>
  </id_info>
  <brief_title>Penicillin and Metronidazole in Treatment of Peritonsillar Abscess</brief_title>
  <official_title>Penicillin and Metronidazole in Treatment of Peritonsillar Abscess - Prospective, Double-blind, Randomized, Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of peritonsillar abscess varies. To study whether broad spectrum antibiotics are
      required in addition to abscess drainage we perform a prospective, double blind,
      placebo-controlled, randomised study on 200 adult patients with peritonsillar abscess. 100
      patients are given penicillin and metronidazole and 100 patients get penicillin and placebo.
      Recovery and recurrence and analyzed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of metronidazole in addition to penicillin in preventing the recurrence of peritonsillar abscess</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Does metronidazole in addition to penicillin enhance the recovery of peritonsillar abscess</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Peritonsillar Abscess</condition>
  <arm_group>
    <arm_group_label>penicillin and metronidazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After incision and drainage 100 randomized patients receive penicillin and metronidazole as treatment of peritonsillar abscess</description>
  </arm_group>
  <arm_group>
    <arm_group_label>penicillin and placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After incision and drainage 100 randomized patients receive penicillin and placebo as treatment of peritonsillar abscess</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>penicillin and metronidazole in peritonsillar abscess</intervention_name>
    <description>Peroral Penicillin: 1000 000 IU 3 times a day for 10 days Peroral metronidazole: 500 mg 3 times a day for 7 days</description>
    <arm_group_label>penicillin and metronidazole</arm_group_label>
    <arm_group_label>penicillin and placebo</arm_group_label>
    <other_name>Medicillin</other_name>
    <other_name>Flagyl</other_name>
    <other_name>Tricozol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  referring doctor suspects peritonsillar abscess

          -  patient is voluntary

          -  patient has daily access to his/her e-mail

          -  patient speaks and understands Finnish of Swedish

          -  female patients have adequate birth-control method

          -  patient has peritonsillar abscess

        Exclusion Criteria:

          -  allergy to penicillin

          -  allergy to metronidazole

          -  use of metronidazole in preceding one month

          -  pregnancy

          -  breast-feeding

          -  renal insufficiency

          -  liver insufficiency

          -  alcoholism (drunk at least once a week)

          -  participant in another clinical trial at the moment

          -  treatment of peritonsillar abscess requires in-patient care

          -  tonsillectomy during the next 30 days

          -  army recruit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karin V Blomgren, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>consultant</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2010</study_first_submitted>
  <study_first_submitted_qc>December 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2010</study_first_posted>
  <last_update_submitted>April 8, 2011</last_update_submitted>
  <last_update_submitted_qc>April 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr Karin Blomgren</name_title>
    <organization>consultant, specialist in otorhinolaryngology</organization>
  </responsible_party>
  <keyword>Peritonsillar Abscess</keyword>
  <keyword>Quinsy</keyword>
  <keyword>Penicillin</keyword>
  <keyword>Metronidazole</keyword>
  <keyword>Recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abscess</mesh_term>
    <mesh_term>Peritonsillar Abscess</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Penicillins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

